269 related articles for article (PubMed ID: 28373363)
1. Re-engineering the Pancreas Tumor Microenvironment: A "Regenerative Program" Hacked.
Evan GI; Hah N; Littlewood TD; Sodir NM; Campos T; Downes M; Evans RM
Clin Cancer Res; 2017 Apr; 23(7):1647-1655. PubMed ID: 28373363
[TBL] [Abstract][Full Text] [Related]
2. Strategies for Increasing Pancreatic Tumor Immunogenicity.
Johnson BA; Yarchoan M; Lee V; Laheru DA; Jaffee EM
Clin Cancer Res; 2017 Apr; 23(7):1656-1669. PubMed ID: 28373364
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic Cancer: "A Riddle Wrapped in a Mystery inside an Enigma".
Borazanci E; Dang CV; Robey RW; Bates SE; Chabot JA; Von Hoff DD
Clin Cancer Res; 2017 Apr; 23(7):1629-1637. PubMed ID: 28373361
[TBL] [Abstract][Full Text] [Related]
4. Current and Emerging Therapies in Metastatic Pancreatic Cancer.
Manji GA; Olive KP; Saenger YM; Oberstein P
Clin Cancer Res; 2017 Apr; 23(7):1670-1678. PubMed ID: 28373365
[TBL] [Abstract][Full Text] [Related]
5. Stromal cues regulate the pancreatic cancer epigenome and metabolome.
Sherman MH; Yu RT; Tseng TW; Sousa CM; Liu S; Truitt ML; He N; Ding N; Liddle C; Atkins AR; Leblanc M; Collisson EA; Asara JM; Kimmelman AC; Downes M; Evans RM
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1129-1134. PubMed ID: 28096419
[TBL] [Abstract][Full Text] [Related]
6. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma.
Tang D; Wang D; Yuan Z; Xue X; Zhang Y; An Y; Chen J; Tu M; Lu Z; Wei J; Jiang K; Miao Y
Int J Cancer; 2013 Mar; 132(5):993-1003. PubMed ID: 22777597
[TBL] [Abstract][Full Text] [Related]
7. Palladin isoforms 3 and 4 regulate cancer-associated fibroblast pro-tumor functions in pancreatic ductal adenocarcinoma.
Alexander JI; Vendramini-Costa DB; Francescone R; Luong T; Franco-Barraza J; Shah N; Gardiner JC; Nicolas E; Raghavan KS; Cukierman E
Sci Rep; 2021 Feb; 11(1):3802. PubMed ID: 33589694
[TBL] [Abstract][Full Text] [Related]
8. [Epithelial-stromal interactions in pancreatic adenocarcinoma: the role of stroma in disease progression].
Kuznetsova AV; Popova OP; Astakhov DA; Ivanov YV; Panchenkov DN; Ivanov AA
Arkh Patol; 2022; 84(5):65-70. PubMed ID: 36178225
[TBL] [Abstract][Full Text] [Related]
9. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
[TBL] [Abstract][Full Text] [Related]
11. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
Fu Y; Liu S; Zeng S; Shen H
Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
[TBL] [Abstract][Full Text] [Related]
12. Gamma-delta T cells stimulate IL-6 production by pancreatic stellate cells in pancreatic ductal adenocarcinoma.
Seifert AM; List J; Heiduk M; Decker R; von Renesse J; Meinecke AC; Aust DE; Welsch T; Weitz J; Seifert L
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3233-3240. PubMed ID: 32865617
[TBL] [Abstract][Full Text] [Related]
13. Substrate Rigidity Controls Activation and Durotaxis in Pancreatic Stellate Cells.
Lachowski D; Cortes E; Pink D; Chronopoulos A; Karim SA; P Morton J; Del Río Hernández AE
Sci Rep; 2017 May; 7(1):2506. PubMed ID: 28566691
[TBL] [Abstract][Full Text] [Related]
14. Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features.
Puleo F; Nicolle R; Blum Y; Cros J; Marisa L; Demetter P; Quertinmont E; Svrcek M; Elarouci N; Iovanna J; Franchimont D; Verset L; Galdon MG; Devière J; de Reyniès A; Laurent-Puig P; Van Laethem JL; Bachet JB; Maréchal R
Gastroenterology; 2018 Dec; 155(6):1999-2013.e3. PubMed ID: 30165049
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer stroma: controversies and current insights.
Ansari D; Carvajo M; Bauden M; Andersson R
Scand J Gastroenterol; 2017; 52(6-7):641-646. PubMed ID: 28276831
[TBL] [Abstract][Full Text] [Related]
16. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
[TBL] [Abstract][Full Text] [Related]
17. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
18. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway.
Chen ST; Kuo TC; Liao YY; Lin MC; Tien YW; Huang MC
Oncogene; 2018 Nov; 37(46):6041-6053. PubMed ID: 29993037
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.
Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M
Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological role of microRNA-29 in pancreatic cancer stroma.
Kwon JJ; Nabinger SC; Vega Z; Sahu SS; Alluri RK; Abdul-Sater Z; Yu Z; Gore J; Nalepa G; Saxena R; Korc M; Kota J
Sci Rep; 2015 Jun; 5():11450. PubMed ID: 26095125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
